MedTrace Logo

NAC Sparing Mastectomy After Neo-adjuvant Chemotherapy

NCT02471742 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 573

Last updated 2015-09-16

No results posted yet for this study

Summary

Nipple areolar-complex (NAC) sparing mastectomy, extending the concept of skin-sparing mastectomy, allows to leave the nipple-areola complex intact and to provide a better cosmetic result. Large operable T2-T3 breast cancer (BC), treated with neoadjuvant chemotherapy, may theoretically appear suitable for this surgical option, alternative to conventional mastectomy or breast conserving surgery in case of unfavorable size of the breast, when a good response to neoadjuvant chemotherapy has been achieved.

Conditions

Interventions

PROCEDURE

NAC-sparing mastectomy

patients treated with mastectomy with conservation of nipple-areola complex

PROCEDURE

conventional mastectomy

patients treated with mastectomy without conservation of nipple-areola complex

Sponsors & Collaborators

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    lead OTHER

Principal Investigators

  • Roberto Agresti, MD · Istituto Tumori Milano

Eligibility

Min Age
23 Years
Max Age
77 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02471742 on ClinicalTrials.gov